PURE Bioscience, Inc. Payments for (Proceeds from) Derivative Instrument, Financing Activities
PURE Bioscience, Inc. (PURE) reported Payments for (Proceeds from) Derivative Instrument, Financing Activities of $1.20 million for the 12-month period ending 2013-07-31, per its 10-Q filed 2014-12-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities · last filed 2015-10-28
- PURE Bioscience, Inc. payments for (proceeds from) derivative instrument, financing activities for fiscal 2012 was $1.20M.
| Period end | Payments for (Proceeds from) Derivative Instrument, Financing Activities | Payments for (Proceeds from) Derivative Instrument, Financing Activities 12 month |
|---|---|---|
| 2013-07-31 | $1.20M 10-Q · filed 2014-12-11 | |
| 2012-07-31 | $1.20M 10-K · filed 2015-10-28 | |
| 2012-07-10 | $1.20M 10-Q · filed 2015-06-11 |